Početna › Rak prostate › Vermont
Kliničke studije za Rak prostate u državi Vermont
5 studija za Rak prostate traži sudionike na lokacijama u državi Vermont.
Gradovi u državi Vermont
Službeni tekst studije (engleski)
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
- Central Vermont Medical Center/National Life Cancer Treatment, Berlin Corners
- University of Vermont Medical Center, Burlington
- University of Vermont and State Agricultural College, Burlington
U tijeku regrutacijaFaza 3
Od 18 godina i više · Muškarci · Ažurirano 2. lis 2026. · NCT06931340Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
- Central Vermont Medical Center/National Life Cancer Treatment, Berlin Corners
- University of Vermont Medical Center, Burlington
- University of Vermont and State Agricultural College, Burlington
- i još 1
U tijeku regrutacijaFaza 3
Od 18 godina i više · Muškarci · Ažurirano 10. ruj 2026. · NCT05946213Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
- Dartmouth Cancer Center - North, Saint Johnsbury
U tijeku regrutacijaFaza 3
Od 18 godina i više · Muškarci · Ažurirano 14. srp 2026. · NCT06592924Fezolinetant for Treating Hot Flashes in Men With Prostate Cancer
- University of Vermont Medical Center, Burlington
U tijeku regrutacijaFaza 2
Od 18 godina i više · Muškarci · Ažurirano 5. velj 2026. · NCT06972875Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
- Central Vermont Medical Center/National Life Cancer Treatment, Berlin Corners
- University of Vermont Medical Center, Burlington
U tijeku regrutacijaFaza 3
Od 18 godina i više · Muškarci · Ažurirano 11. ruj 2025. · NCT03678025Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.